Shuttling imbalance of MLF1 results in p53 instability and increases susceptibility to oncogenic transformation

Molecular and Cellular Biology

Volumn 28, Issue 1, 2008, Pages 422-434

  Yoneda Kato, Noriko ^a   Kato, Jun Ya ^a  

^a NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COP9 SIGNALOSOME; MYELOID LEUKEMIA FACTOR 1; NUCLEOPHOSMIN; PROTEIN; PROTEIN P53; UBIQUITIN PROTEIN LIGASE COP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRESS; CHROMOSOME 3Q; CHROMOSOME 5Q; CHROMOSOME TRANSLOCATION 3; CHROMOSOME TRANSLOCATION 5; CONTROLLED STUDY; FIBROBLAST; GENOTOXICITY; GROWTH INHIBITION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUCLEAR EXPORT SIGNAL; NUCLEOLUS; PRIORITY JOURNAL;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CONSERVED SEQUENCE; HEMATOPOIETIC STEM CELLS; HUMANS; KARYOPHERINS; MICE; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SEQUENCE ALIGNMENT; TUMOR SUPPRESSOR PROTEIN P53;

MURINAE;

EID: 37549032778     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.02335-06     Document Type: Article

References (50)

1. Bates, S., A. C. Phillips, P. A. Clark, F. Stott, G. Peters, R. L. Ludwig, and K. H. Vousden. 1998. p14ARF links the tumour suppressors RB and p53. Nature 395:124-125.
2. Bertwistle, D., M. Sugimoto, and C. J. Sherr. 2004. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol. Cell. Biol. 24:985-996.
3. Bischof, D., K. Pulford, D. Y. Mason, and S. W. Morris. 1997. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol. Cell. Biol. 17:2312-2325.
4. Borer, R. A., C. F. Lehner, H. M. Eppenberger, and E. A. Nigg. 1989. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56:379-390.
5. Chan, T. A., H. Hermeking, C. Lengauer, K. W. Kinzler, and B. Vogelstein. 1999. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 401:616-620.
6. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
7. Colombo, E., J. C. Marine, D. Danovi, B. Falini, and P. G. Pelicci. 2002. Nucleophosmin regulates the stability and transcriptional activity of p53. Nat. Cell Biol. 4:529-533.
8. Colombo, E., P. Martinelli, R. Zamponi, D. C. Shing, P. Bonetti, L. Luzi, S. Volorio, L. Bernard, G. Pruneri, M. Alcalay, and P. G. Pelicci. 2006. Derealization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant. Cancer Res. 66:3044-3050.
9. den Besten, W., M. L. Kuo, R. T. Williams, and C. J. Sherr. 2005. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein. Cell Cycle 4:1593-1598.
10. Dornan, D., H. Shimizu, A. Mah, T. Dudhela, M. Eby, K. O'Rourke, S. Seshagiri, and V. M. Dixit. 2006. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage. Science 313:1122-1126.
11. Dornan, D., I. Wertz, H. Shimizu, D. Arnott, G. D. Frantz, P. Dowd, K. O'Rourke, H. Koeppen, and V. M. Dixit. 2004. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429:86-92.
12. Engelsma, D., R. Bernad, J. Calafat, and M. Fornerod. 2004. Supraphysiological nuclear export signals bind CRM1 independently of RanGTP and arrest at Nup358. EMBO J. 23:3643-3652.
13. Falini, B., C. Mecucci, E. Tiacci, M. Alcalay, R. Rosati, L. Pasqualucci, R. La Starza, D. Diverio, E. Colombo, A. Santucci, B. Bigerna, R. Pacini, A. Pucciarini, A. Liso, M. Vignetti, P. Fazi, N. Meani, V. Pettirossi, G. Saglio, F. Mandelli, F. Lo-Coco, P. G. Pelicci, and M. F. Martelli. 2005. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N. Engl. J. Med. 352:254-266.
14. Fornerod, M., M. Ohno, M. Yoshida, and I. W. Mattaj. 1997. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90:1051-1060.
15. Fu, H., R. R. Subramanian, and S. C. Masters. 2000. 14-3-3 proteins: structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 40:617-647.
16. Fukuda, M., S. Asano, T. Nakamura, M. Adachi, M. Yoshida, M. Yanagida, and E. Nishida. 1997. CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 390:308-311.
17. Hanissian, S. H., U. Akbar, B. Teng, Z. Janjetovic, A. Hoffmann, J. K. Hitzler, N. Iscove, K. Hamre, X. Du, Y. Tong, S. Mukatira, J. H. Robertson, and S. W. Morris. 2004. cDNA cloning and characterization of a novel gene encoding the MLF1-interacting protein MLF1IP. Oncogene 23:3700-3707.
18. Hawley, R. G., F. H. Lieu, A. Z. Fong, and T. S. Hawley. 1994. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1:136-138.
19. Hingorani, K., A. Szebeni, and M. O. Olson. 2000. Mapping the functional domains of nucleolar protein B23. J. Biol. Chem. 275:24451- 24457.
20. Itahana, K., K. P. Bhat, A. Jin, Y. Itahana, D. Hawke, R. Kobayashi, and Y. Zhang. 2003. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol. Cell 12:1151-1164.
21. Korgaonkar, C., J. Hagen, V. Tompkins, A. A. Frazier, C. Allamargot, F. W. Quelle, and D. E. Quelle. 2005. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function. Mol. Cell. Biol. 25:1258-1271.
22. Kurokawa, K., T. Tanaka, and J. Kato. 1999. p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts. Oncogene 18:2718-2727.
23. Kutay, U., and S. Guttinger. 2005. Leucine-rich nuclear-export signals: born to be weak. Trends Cell Biol. 15:121-124.
24. Lavin, M. F., D. Delia, and L. Chessa. 2006. ATM and the DNA damage response. Workshop on ataxia-telangiectasia and related syndromes. EMBO Rep. 7:154-160.
25. Lim, R., L. N. Winteringham, J. H. Williams, R. K. McCulloch, E. Ingley, J. Y. Tiao, J. P. Lalonde, S. Tsai, P. A. Tilbrook, Y. Sun, X. Wu, S. W. Morris, and S. P. Klinken. 2002. MADM, a novel adaptor protein that mediates phosphorylation of the 14-3-3 binding site of myeloid leukemia factor 1. J. Biol. Chem. 277:40997-41008.
26. Lopez-Girona, A., B. Furnari, O. Mondesert, and P. Russell. 1999. Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature 397:172-175.
27. Matsumoto, N., N. Yoneda-Kato, T. Iguchi, Y. Kishimoto, T. Kyo, H. Sawada, E. Tatsumi, and S. Fukuhara. 2000. Elevated MLF1 expression correlates with malignant progression from myelodysplastic syndrome. Leukemia 14:1757-1765.
28. Morris, S. W., M. N. Kirstein, M. B. Valentine, K. G. Dittmer, D. N. Shapiro, D. L. Saltman, and A. T. Look. 1994. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281-1284.
29. Morrison, D. K., and R. E. Cutler. 1997. The complexity of Raf-1 regulation. Curr. Opin. Cell Biol. 9:174-179.
30. Ohno, K., Y. Takahashi, F. Hirose, Y. H. Inoue, O. Taguchi, Y. Nishida, A. Matsukage, and M. Yamaguchi. 2000. Characterization of a Drosophila homologue of the human myelodysplasia/myeloid leukemia factor (MLF). Gene 260:133-143.
31. Okuda, M., H. F. Horn, P. Tarapore, Y. Tokuyama, A. G. Smulian, P. K. Chan, E. S. Knudsen, I. A. Hofmann, J. D. Snyder, K. E. Bove, and K. Fukasawa. 2000. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 103:127-140.
32. Palmero, I., C. Pantoja, and M. Serrano. 1998. p19ARF links the tumour suppressor p53 to Ras. Nature 395:125-126.
33. Raimondi, S. C., I. D. Dube, M. B. Valentine, J. Mirro, Jr., H. J. Watt, R. A. Larson, M. A. Bitter, M. M. Le Beau, and J. D. Rowley. 1989. Clinicopathologic manifestations and breakpoints of the t(3;5) in patients with acute nonlymphocytic leukemia. Leukemia 3:42-47.
34. Redner, R. L., J. D. Chen, E. A. Rush, H. Li, and S. L. Pollock. 2000. The t(5;17) acute promyelocytic leukemia fusion protein NPM-RAR interacts with co-repressor and co-activator proteins and exhibits both positive and negative transcriptional properties. Blood 95:2683-2690.
35. Redner, R. L., E. A. Rush, S. Faas, W. A. Rudert, and S. J. Corey. 1996. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood 87:882-886.
36. Schwechheimer, C., and X. W. Deng. 2001. COP9 signalosome revisited: a novel mediator of protein degradation. Trends Cell Biol. 11:420-426.
37. Serrano, M., A. W. Lin, M. E. McCurrach, D. Beach, and S. W. Lowe. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602.
38. Sun, W., K. Zhang, X. Zhang, W. Lei, T. Xiao, J. Ma, S. Guo, S. Shao, H. Zhang, Y. Liu, J. Yuan, Z. Hu, Y. Ma, X. Feng, S. Hu, J. Zhou, S. Cheng, and Y. Gao. 2004. Identification of differentially expressed genes in human lung squamous cell carcinoma using suppression subtractive hybridization. Cancer Lett. 212:83-93.
39. Sun, Y., M. P. Wilson, and P. W. Majerus. 2002. Inositol 1,3,4-trisphosphate 5/6-kinase associates with the COP9 signalosome by binding to CSN1. J. Biol. Chem. 277:45759-45764.
40. Todaro, G. J., and H. Green. 1963. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17:299-313.
41. Tomoda, K., Y. Kubota, Y. Arata, S. Mori, M. Maeda, T. Tanaka, M. Yoshida, N. Yoneda-Kato, and J. Y. Kato. 2002. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J. Biol. Chem. 277:2302-2310.
42. Tomoda, K., Y. Kubota, and J. Kato. 1999. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398:160-165.
43. Uhle, S., O. Medalia, R. Waldron, R. Dumdey, P. Henklein, D. Bech-Otschir, X. Huang, M. Berse, J. Sperling, R. Schade, and W. Dubiel. 2003. Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome. EMBO J. 22:1302-1312.
44. Wang, W., A. Budhu, M. Forgues, and X. W. Wang. 2005. Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication. Nat. Cell Biol. 7:823-830.
45. Winteringham, L. N., R. Endersby, S. Kolbeke, R. K. McCulloch, J. H. Williams, J. Stillitano, S. M. Cornwall, E. Ingley, and S. P. Klinken. 2006. Myeloid leukemia factor 1 associates with a novel hnRNP-U-like molecule. J. Biol. Chem. 281:38791-38800.
46. Yoneda-Kato, N., A. T. Look, M. N. Kirstein, M. B. Valentine, S. C. Raimondi, K. J. Cohen, A. J. Carroll, and S. W. Morris. 1996. The t(3;5)(q25.1;q34) of myeiodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene 12:265-275.
47. Yoneda-Kato, N., K. Tomoda, M. Umehara, Y. Arata, and J. Y. Kato. 2005. Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3. EMBO J. 24:1739-1749.
48. Yoshida, M., and S. Horinouchi. 1999. Trichostatin and leptomycin. Inhibition of histone deaeetylation and signal-dependent nuclear export. Ann. N. Y. Acad. Sci. 886:23-36.
49. Yung, B. Y., H. Busch, and P. K. Chan. 1985. Translocation of nucleolar phosphoprotein B23 (37 kDa/pI 5.1) induced by selective inhibitors of ribosome synthesis. Biochim. Biophys. Acta 826:167-173.
50. Zindy, F., R. T. Williams, T. A. Baudino, J. E. Rehg, S. X. Skapek, J. L. Cleveland, M. F. Roussel, and C. J. Sherr. 2003. Arf tumor suppressor promoter monitors latent oncogenic signals in vivo. Proc. Natl. Acad. Sci. USA 100:15930-15935.